Immunophenotypic profiles of peripheral blood lymphocytes on the day of embryo transfer in women undergoing in vitro fertilization. by Baczkowski, Tomasz & Kurzawa, Rafał
Introduction
Idiopathic infertility and IVF failure may have
immunological background. However, the immuno-
logical assessment has a lot of limitations. Only a few
examinations have significance in reproductive med-
icine. Evaluation of different types of lymphocyte
subpopulations in the peripheral blood and in
endometrial tissue has unknown and controversial
significance in diagnosis of infertility or recurrent
miscarriages [1,2]. Since there is no clear cause for at
least of 20% of infertility cases, immunologists try to
link reproductive failure with immunological back-
ground. Some laboratories offer infertile patients the
evaluation of reproductive immunophenotypes. The
count of total peripheral blood NK cells
(CD56+CD16-, CD56+CD16+ and CD56-CD16+)
should be lower than 12% of lymphocytes. However,
some authors report higher normal levels, even up to
29% of lymphocytes [3,4]. On the other hand, sever-
al authors do not confirm that the elevated propor-
tions of NK cells have significant influence on repro-
ductive failure [5,6]. The fact that the endometrial
NK cells subpopulation differs from peripheral blood
NK cells subpopulation can additionally explain the
limitation of such a examination. At the time of
implantation, NK cells make up 70-90 % of lympho-
cytes in the endometrium [7]. These NK lymphocytes
have significant expression of CD56 and lack of
CD16 antigen (CD56brightCD16-). They are less cyto-
toxic than the subpopulation with lower expression of
CD56 (CD56dimCD16+ or CD56dimCD16-) that rep-
resents up to 90% of peripheral blood NK cells. The
others peripheral blood NK cells have following
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phenotypes: CD56-CD16+, CD56brightCD16+ or
CD56brightCD16-. 
Lack of evidence that the NK cells has quite a lim-
ited value in diagnosis of infertility, causes that also
other subpopulations of the lymphocytes or others
markers are evaluated. Different panels (CD3, CD4,
CD5, CD8, CD16, CD19, CD27, CD56, and CD94)
and combinations of CD antigens are used in the stud-
ies to define the range of standard values and to deter-
mine their impact on reproduction [2,8,9]. That
allowed to recognize the T (CD3+, D3+CD4+,
CD3+CD8+), B (CD19+, CD5+CD19+), T and B
(CD5+) lymphocytes and NK cells (with expressions
of CD56 or CD16). Additionally, in the latest studies,
an early activation antigen (CD69) was evaluated in
this setting. It was reported that increased levels of
CD69 positive cells can be responsible for reproduc-
tive failure [8]. Objective of the current study was to
evaluate the expression of different types of
immunophenotypes in lymphocytes of patients treated
with intracytoplasmic sperm injection (ICSI). 
Materials and methods
Fifty eight women qualified to ICSI with good outcome prognosis
treated from November 2006 to May 2007 and 18 fertile women as
a control group were enrolled in the study. Patients treated with
ICSI were divided into two groups: pregnant women (n = 32) and
women that did not achieve a pregnancy after ICSI (n = 26). 
The inclusion criteria were: age of <35 years; normal gynecol-
ogical, hormonal and anatomical state; concentration of the sperm
>5 mln/ml; at least three good embryos on the third day of culture,
evaluated 18-20h after ICSI procedure as an optimal zygotes
according to Scott; easy embryo transfer. The history of abortions,
PID, curettage, hydrosalpinx, endometriosis, endocrinological and
metabolical diseases; ≥1 ICSI/ET procedure; gynecological inter-
ventions (leyomyomas, endometrial polyps, pelvic adhesions
removal) were the exclusion criteria. The inclusion criteria for con-
trol group were: age of <35 years; normal gynecological, hormonal
and anatomical state, confirmed fertility - minimum two deliveries,
no history of miscarriages nor complications of the pregnancy.
IVF procedure. Long GnRH agonist protocol with triptorelin
(Diphereline SR 3,75; Boufor Ibsen Pharma, France) or short GnRH
antagonist protocol with cetrorelix 3 mg (Cetrotide; Merck Serono,
Germany) along with recombined follitropin alfa (Gonal F; Serono
Pharma, Switzerland) or menotropin (Menopur, Ferring Pharmacuti-
calis, Switzerland) and human choriogonadotropin (Ovitrelle; Merck
Serono, France) were used. Transvaginal oocyte retrieval was per-
formed 36 hours after Ovitrelle injections under systemic analgesia.
All patients underwent ICSI procedure. After oocyte retrieval luteal
phase was supported by intravaginal progesterone (Luteina, Adamed,
Poland) and oral administration of dydrogesterone (Duphaston,
Solvay Pharmaceuticalis, Germany). The embryos were evaluated at
the first day 18-20h after ICSI procedure according to the Scott crite-
ria and on the 3rd day of culture. Transfer of two embryos on the 3rd
day of culture was performed with Soft Frydman catheter. 
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Table 1. The fractions of different lymphocyte subpopulations in peripheral blood, presented as a percentage [%] of total lymphocytes.
control - fertile patients; pregnant - patients that achieved pregnancy after ICSI; non-pregnant - patients that did not achieve pregnancy after ICSI; NS =
not significant; agroups with significant differences (p<0.05) 
Flow cytometry. Three-color flow cytometry (FACS Calibur) was
used to evaluate different subpopulation of the mononuclear cells.
The examination was done on the fresh blood on the day of the
transfer. The differently labeled monoclonal antibodies in follow-
ing combinations were used: CD3 PerCP, CD45 PerCP, CD5 FITC
CD19 PE, CD16 FITC CD56 PE, CD19 FITC CD 69PE, CD56
FITC CD69 PE, CD56 FITC, CD4 FITC CD69 PE, and CD8 FITC
CD69 PE. All the reagents were produced by Becton Dickinson (B-
D Biosciences USA). The subpopulations of mononuclear lym-
phocytes with following CD antigens were analyzed: CD3, CD5,
CD19, CD5+CD19+, CD19+CD69+, CD3+CD4+CD69+,
CD3+CD8+CD69+, CD56+CD16-, CD56-CD16+, CD56+CD16+,
CD56+CD69+ and depending on expressions of CD56 -
CD56brightCD16 and CD56dimCD16+. 
The results were presented as a percentage of total lympho-
cytes and after calculation as a total count in n/μL
. 
Ethical issues. All women gave informed consent according to the
Medical Ethical Committee guidelines. 
Statistical analysis. Non-parametric ANOVA was used to detect
statistical differences in mean percentages and counts of leukocyte
subpopulations. P value <0,05 was considered as significant. All
calculations were performed using Statistica for Windows 7.1
(StatSoft Inc., Tulsa;USA). 
Results
The mean age between women who achieved, did not
achieve a pregnancy and control group did not differ
significantly (31,6 years vs. 32,6 years vs. 32,4,
respectively). The pregnancy ratio among ICSI-treated
and included in the study patients was 55,1% and it
was significantly higher comparing to 42% among all
patients treated with ICSI between November 2006
and May 2007 (126 patients, 53 pregnancies). Levels
of NK cells (total CD56+CD16+, CD56+CD16- and
CD56-CD16+) do not differ between patients that
achieved and did not achieve pregnancy after ICSI.
Surprisingly, the level of total NK was significantly
higher in control group in comparison to not-pregnant
women (19,6% vs.12,71%).
Population of CD56-CD16+ was significantly
higher in pregnant women comparing to non-pregnant
(1,86% vs. 1,08%, respectively). The evaluation of
CD56 expression revealed that the percentage of NK
cells with high expression of CD56 (CD56bright) is sig-
nificantly higher in control group comparing to both
pregnant and non-pregnant patients. Other subpopula-
tions, such as a total mononuclear lymphocytes,
CD3+, CD19+, CD5+CD19+, CD3+CD4+CD69+,
CD3+CD8+CD69+, CD19+CD69+, CD56+CD69+
did not differ between analyzed groups of patients.
Only percentage of lymphocytes T and B (CD5+) was
higher in control group comparing to women that did
not achieve pregnancy after ICSI. Results are shown in
Table 1. 
Total counts of analyzed subpopulations of lym-
phocytes differed significantly only in CD56-CD16+
subpopulation in pregnant and non-pregnant group (46
cells/μL vs. 23 cells/μL, respectively), but while com-
pared to fertile patients the statistical significance was
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Table 2. The total counts [n/μl] of different subpopulations of lymphocytes in peripheral blood.
control - fertile patients; pregnant - patients that achieved pregnancy after ICSI; non-pregnant - patients that did not achieve pregnancy after ICSI; NS =
not significant; agroups with significant differences (p<0.05) 
not seen (34cells/μL vs. 46cells/μL and vs.
23cells/μL). Although the level of NK cells was high-
er in control and pregnant group than in non-pregnant
group (453cells/μL vs. 416cells/μL vs. 269cells/μL,
respectively) the differences were not significant. The
evaluation of CD56 expression showed that in control
group the level of NK cells with high expressions of
CD56 was significantly higher when compared to
pregnant and non-pregnant patients. The other subpop-
ulations did not differ significantly between the stud-
ied groups of patients. Results are shown in Table 2.
Discussion
Many studies try to confirm connection between levels
of certain lymphocyte subpopulations and reproduc-
tive failure. The best documented studies were per-
formed on patients with recurrent miscarriages [1,4].
The increased levels of NK cells is proposed to be con-
nected with higher risk of pregnancy loss and idio-
pathic infertility. Some authors consider that cut off
value of 12% of NK cells should be recognized as a
reference level [1,3,10]. In the current study the frac-
tion of NK cells was increased - 17,62% in pregnant,
12,71% in non-pregnant women and surprisingly -
19,6% in fertile patients. The percentage of NK cells
observed in our study was relatively high and reached
the levels in recurrent abortions or in patients with
repeated IVF failure reported in publications [10,11].
Surprisingly, the fractions of NK cells in our study was
the highest in control group (fertile patients). Elevated
levels of NK cells has been reported to be associated
with lower pregnancy rates in assisted reproduction
and higher risk of spontaneous abortion [1,3,12]. Our
study did not confirm that thesis. This lack of useful-
ness of NK cells examination in patients with recurrent
spontaneous abortions and in idiopathic infertility has
recently been also shown in other studies [2,6] and in
terms of reported NK counts cells corresponds to our
results.
In our study, the percentage and the total counts of
CD56+CD16- NK cells subpopulation was relatively
higher than reported by other authors [12,13]. Some
studies have shown that the levels of CD56brightCD16-
cells may be used in diagnosis of idiopathic infertility
and recurrent miscarriages because of its phonotypical
similarity to the uterine endometrial subpopulation of
NK cells. Increased levels of this subpopulation may
be observed in fertile women when compared to infer-
tile patients or those with recurrent spontaneous mis-
carriages [11,13]. But the study results are controver-
sial and are not confirmed in randomized studies. In
our study we showed that the total counts and the per-
centage of CD56brightCD16- in control group were sig-
nificantly higher than in women treated either success-
fully or unsuccessfully with ICSI. The level of NK
cells with low expression of CD56 (CD56dimCD16+)
was comparable in every studied group.
Recent studies try to assess the early activation
marker on some types of lymphocytes. It has been
reported that the elevated proportions of
CD56+CD69+ are connected with infertility and
recurrent abortions [5,8,12]. In the current study, the
proportion of CD56+CD69+ to total CD56+ cells was
high, and it was comparable to the fractions of
CD56+69+ cells reported for infertile patients and
patients with recurrent miscarriages. However, in our
study we did not see the difference between fertile
patients (control group) and both ICSI treated groups.
Other studies reported that the levels of CD56+69+ in
peripheral blood in fertile patients is significantly
lower comparing to groups with recurrent spontaneous
abortions and with infertility [11,14,16], however this
has not been reflected in our experiments.
Other subpopulations of lymphocytes like lympho-
cytes T (CD3) or B (CD19) were similar in the studied
groups, as it was also shown in other reports [9,15].
Also, the presence of early activation marker CD69 on
the CD4, CD8 and CD19 positive cells did not differ
significantly in both ICSI treated groups and control
fertile patients. Also these sets of results were compa-
rable to data reported by other authors, concluding that
the fractions and levels of CD69+ positive cells did not
correspond with any clinical form of the reproductive
failures [2,16,17]. 
Selection of patients may limit conclusions origi-
nating from our study. Idiopathic infertility is a diag-
nosis from exclusion, and as such may not be clearly
identified. Needless to say, such a limitation concerns
vast majority of the published studies, therefore dis-
cordant results on the role of different subpopulations
of blood lymphocytes in pathogenesis of reproductive
failure will blur the true significance of immunity in
human reproduction. 
Nevertheless, also keeping in mind the limitations
of the current study, our results adhere largely to data
presented in numerous recent publications not recom-
mending immunophenotyping as an important diag-
nostic tool in reproductive medicine [6]. 
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